Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular CarcinomaJennifer L. Leiting(Mayo Clinic), Mark J. Truty(Mayo Clinic in Arizona)In VivoJanuary 1, 202310.21873/invivo.13290Cited by 4SaveCiteExport RISWatch citationsRelated PapersRadiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database|Journal of Clinical Oncology|2018|195